Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  UnitedHealth Group    UNH

UNITEDHEALTH GROUP (UNH)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales130 474157 107184 828200 590222 817240 535
EBITDA11 75212 71415 33517 35820 35022 857
Operating profit (EBIT)10 27411 67214 16215 35117 95220 347
Pre-Tax Profit (EBT)------
Net income5 6195 8137 2379 25110 04611 417
P/E ratio17,719,621,423,821,819,0
EPS ( $ )5,706,017,489,4210,311,8
Dividend per Share ( $ )1,411,882,382,512,773,38
Yield1,39%1,60%1,48%1,12%1,23%1,51%
Reference price ( $ )101.09117.64160.04224.35224.35224.35
Announcement Date01/21/2015
11:00am
01/19/2016
10:55am
01/17/2017
10:55am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt8 17019 18319 69515 1709 8944 818
Finance------
Operating income (EBITDA)11 75212 71415 33517 35820 35022 857
Leverage
(Debt/EBITDA)
0,70x1,51x1,28x0,87x0,49x0,21x
Capital Expenditure1 4471 5561 7051 8402 0322 191
Book Value Per Share (BVPS)33,7 $35,4 $40,3 $51,1 $56,7 $63,1 $
Cash Flow per Share8,16 $10,1 $10,1 $16,0 $14,7 $16,4 $
Announcement Date01/21/2015
11:00am
01/19/2016
10:55am
01/17/2017
10:55am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 216 915 M$ -
Entreprise Value (EV) 232 085 M$ 226 809 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 23,8x 21,8x
Capitalization / Revenue 1,08x 0,97x
EV / Revenue 1,16x 1,02x
EV / EBITDA 13,4x 11,1x
Yield (DPS / Price) 1,12% 1,23%
Price to book (Price / BVPS) 4,39x 3,96x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 7,65% 8,06%
operating Leverage (Delta EBIT / Delta Sales) 0,98x 1,53x
Net Margin (Net Profit / Revenue) 4,61% 4,51%
ROA (Net Profit / Asset) 8,34% 8,60%
ROE (Net Profit / Equities) 21,3% 20,1%
Rate of Dividend 26,7% 26,9%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   0,92% 0,91%
Cash Flow / Sales 7,71% 6,40%
Capital Intensity (Assets / Sales) 0,55x 0,52x
Financial Leverage (Net Debt / EBITDA) 0,87x 0,49x
EPS & Dividend